These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34413930)

  • 1. DNA-Aptamer Raised against Receptor for Advanced Glycation End Products Improves Survival Rate in Septic Mice.
    Koga Y; Sotokawauchi A; Higashimoto Y; Nishino Y; Hashizume N; Kakuma T; Akiba J; Tanaka Y; Matsui T; Yagi M; Yamagishi SI
    Oxid Med Cell Longev; 2021; 2021():9932311. PubMed ID: 34413930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxymatrine attenuates sepsis-induced inflammation and organ injury via inhibition of HMGB1/RAGE/NF-κB signaling pathway.
    He J; Qin W; Jiang S; Lin Y; Lin Y; Yang R; Xu M; Liu Q
    Drug Dev Res; 2024 Jun; 85(4):e22219. PubMed ID: 38845211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice.
    Sotokawauchi A; Matsui T; Higashimoto Y; Nishino Y; Koga Y; Yagi M; Yamagishi SI
    Diab Vasc Dis Res; 2021; 18(1):1479164121990533. PubMed ID: 33535822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-129-5p alleviates LPS-induced acute kidney injury via targeting HMGB1/TLRs/NF-kappaB pathway.
    Huang X; Hou X; Chuan L; Wei S; Wang J; Yang X; Ru J
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107016. PubMed ID: 33039954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.
    Matsui T; Higashimoto Y; Nishino Y; Nakamura N; Fukami K; Yamagishi SI
    Diabetes; 2017 Jun; 66(6):1683-1695. PubMed ID: 28385802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice.
    Ren Q; Guo F; Tao S; Huang R; Ma L; Fu P
    Biomed Pharmacother; 2020 Feb; 122():109772. PubMed ID: 31918290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Receptor for Advanced Glycation Endproducts (RAGE) Contributes to Severe Inflammatory Liver Injury in Mice.
    Weinhage T; Wirth T; Schütz P; Becker P; Lueken A; Skryabin BV; Wittkowski H; Foell D
    Front Immunol; 2020; 11():1157. PubMed ID: 32670276
    [No Abstract]   [Full Text] [Related]  

  • 8. Penehyclidine hydrochloride inhibits the release of high-mobility group box 1 in lipopolysaccharide-activated RAW264.7 cells and cecal ligation and puncture-induced septic mice.
    Yang Q; Liu X; Yao Z; Mao S; Wei Q; Chang Y
    J Surg Res; 2014 Jan; 186(1):310-7. PubMed ID: 24124976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Septic shock is associated with receptor for advanced glycation end products ligation of LPS.
    Yamamoto Y; Harashima A; Saito H; Tsuneyama K; Munesue S; Motoyoshi S; Han D; Watanabe T; Asano M; Takasawa S; Okamoto H; Shimura S; Karasawa T; Yonekura H; Yamamoto H
    J Immunol; 2011 Mar; 186(5):3248-57. PubMed ID: 21270403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAGE-aptamer Attenuates the Growth and Liver Metastasis of Malignant Melanoma in Nude Mice.
    Nakamura N; Matsui T; Ishibashi Y; Sotokawauchi A; Fukami K; Higashimoto Y; Yamagishi SI
    Mol Med; 2017 Nov; 23():295-306. PubMed ID: 29387865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance.
    Aneja RK; Tsung A; Sjodin H; Gefter JV; Delude RL; Billiar TR; Fink MP
    J Leukoc Biol; 2008 Nov; 84(5):1326-34. PubMed ID: 18687905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucan phosphate attenuates myocardial HMGB1 translocation in severe sepsis through inhibiting NF-κB activation.
    Ha T; Xia Y; Liu X; Lu C; Liu L; Kelley J; Kalbfleisch J; Kao RL; Williams DL; Li C
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H848-55. PubMed ID: 21642503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine inhibits LPS-induced HGMB1 release in vitro and in vivo.
    Zhang Z; Zhang L; Zhou C; Wu H
    Int Immunopharmacol; 2014 Nov; 23(1):14-26. PubMed ID: 25133650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of HMGB1-RAGE/TLRs-NF-κB signaling pathway on bone mesenchymal stem cells transplantation therapy for lipopolysaccaride-induced coagulation disorder rats].
    Xiu G; Xiong W; Yin Y; Chen X; Liu P; Sun J; Ling B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Sep; 30(9):830-835. PubMed ID: 30309407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression of lncRNA NEAT1 Antagonizes LPS-Evoked Acute Injury and Inflammatory Response in Alveolar Epithelial Cells via HMGB1-RAGE Signaling.
    Zhou H; Wang X; Zhang B
    Mediators Inflamm; 2020; 2020():8019467. PubMed ID: 32089649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine attenuates sepsis-induced acute lung injury via regulation of HMGB1-RAGE pathways.
    Li K; Yang J; Han X
    Int Immunopharmacol; 2016 May; 34():114-128. PubMed ID: 26945830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gensenoside Rg1 protects against lipopolysaccharide- and d-galactose-induced acute liver failure via suppressing HMGB1-mediated TLR4-NF-κB pathway.
    Jin H; Jiang Y; Lv W; Chen L; Zheng Y; Lin Y
    Mol Cell Probes; 2021 Apr; 56():101706. PubMed ID: 33617946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
    Good DW; George T; Watts BA
    Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ameliorative effect of a rarely occurring C-methylrotenoid on HMGB1-induced septic responses in vitro and in vivo.
    Yang EJ; Lee W; Song KS; Bae JS
    Biochem Pharmacol; 2016 Jun; 110-111():58-70. PubMed ID: 27106082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy of Ulinastatin with Thrombomodulin alleviates endotoxin (LPS) - induced liver and kidney injury via inhibiting apoptosis, oxidative stress and HMGB1/TLR4/NF-κB pathway.
    Zhang X; Su C; Zhao S; Li J; Yu F
    Bioengineered; 2022 Feb; 13(2):2951-2970. PubMed ID: 35148668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.